chr3-2571534-C-A
Variant summary
Our verdict is Likely benign. The variant received -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_175607.3(CNTN4):c.31C>A(p.Gln11Lys) variant causes a missense change. The variant allele was found at a frequency of 0.0000731 in 1,613,692 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Synonymous variant affecting the same amino acid position (i.e. Q11Q) has been classified as Likely benign.
Frequency
Consequence
NM_175607.3 missense
Scores
Clinical Significance
Conservation
Publications
- complex neurodevelopmental disorderInheritance: AD Classification: LIMITED Submitted by: ClinGen
- autism spectrum disorderInheritance: AD Classification: NO_KNOWN Submitted by: Illumina
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -6 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000328 AC: 5AN: 152232Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.0000200 AC: 5AN: 249392 AF XY: 0.0000296 show subpopulations
GnomAD4 exome AF: 0.0000773 AC: 113AN: 1461460Hom.: 0 Cov.: 30 AF XY: 0.0000784 AC XY: 57AN XY: 727038 show subpopulations
GnomAD4 genome AF: 0.0000328 AC: 5AN: 152232Hom.: 0 Cov.: 33 AF XY: 0.0000269 AC XY: 2AN XY: 74382 show subpopulations
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.31C>A (p.Q11K) alteration is located in exon 3 (coding exon 1) of the CNTN4 gene. This alteration results from a C to A substitution at nucleotide position 31, causing the glutamine (Q) at amino acid position 11 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at